Jyong BiotechMENS
13F holders, Q2 2026 (June 30)19holders +2
5new positions
3sold out
1famous investor
$2.07avg. 13F price*
At the end of Q2 2026, 19 institutions reported holding Jyong Biotech Ltd. (MENS) in their 13F filings, up 2 from Q1 2026. 5 opened new positions and 3 sold out. The largest holders were BlackRock, Inc. ($539K), Geode Capital Management, LLC ($143K) and HRT Financial LP ($104K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Jyong Biotech Ltd.
- CUSIP
- G83116106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $131K |
| Exits | 3 | $62K |
All 13F filers, Q1 2026 → Q2 2026: 109,851 shares bought and 75,438 shares sold, net +34,413 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| BlackRock, Inc. | 0.00% | Add +0.6% | 260,317 | $539K |
| Geode Capital Management, LLC | 0.00% | Add +7.2% | 68,882 | $143K |
| HRT Financial LP | 0.00% | Add +328.5% | 50,423 | $104K |
| XTX Topco Ltd | 0.00% | New | 29,066 | $60K |
| Renaissance Technologies | 0.00% | New | 22,900 | $47K |
| China Universal Asset Management Co., Ltd. | 0.00% | Reduce -8.2% | 12,100 | $25K |
| State of Wyoming | 0.00% | New | 11,208 | $23K |
| Morgan Stanley | 0.00% | Reduce -3.0% | 6,112 | $13K |
| Barclays PLC | 0.00% | Add +14.3% | 5,931 | $12K |
| JPMorgan Chase & Co. | 0.00% | Reduce -5.3% | 5,379 | $12K |
| UBS Group AG | 0.00% | Reduce -89.2% | 4,046 | $8K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Reduce -12.2% | 3,400 | $7K |
| BNP Paribas Financial Markets | 0.00% | Add +44.1% | 2,710 | $6K |
| Citigroup Inc. | 0.00% | Reduce -10.3% | 2,501 | $5K |
| GF Fund Management Co. LTD. | 0.00% | Reduce -7.0% | 1,559 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -90.9% | 1,070 | $2K |
| Cornerstone Financial Management LLC | 0.00% | New | 234 | $484 |
| Bell Investment Advisors, Inc | 0.00% | Reduce -56.5% | 206 | $427 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 9 | $19 |
"% of holder's portfolio" is MENS's weight in each manager's 13F, not the share of Jyong Biotech Ltd. the manager owns.